↓ Skip to main content
NCW
  1. Health/

The Fish Oil Evidence Is Messier Than Either Side Admits

·1000 words·5 mins· loading · loading · ·
Nutrition Cardiovascular Health Cognitive Bias
Neo W.
Author
Neo W.
Writing about things that intrigue me.
Table of Contents

The Fish Oil Evidence Is Messier Than Either Side Admits
#

Two large randomised trials found standard-dose fish oil didn’t prevent heart attacks or strokes in healthy people. That’s the strongest argument against the capsule — and the popular follow-up claim, that it also causes atrial fibrillation, turns out to apply mainly to doses far above what’s in the bottle.

What the big trials actually found
#

Two major randomised controlled trials tested standard-dose omega-3 against placebo — one following around 25,000 generally healthy adults, another around 15,000 people with diabetes. On heart attack, stroke and premature death, neither found meaningful benefit over placebo.

For a healthy person taking a daily capsule specifically for heart protection, that is the central finding, and it hasn’t been overturned.

The prescription exception, and why it’s contested
#

REDUCE-IT gave 4 g/day of purified EPA — prescription-strength, not an over-the-counter product — to high-risk patients already on statins with elevated triglycerides, and reported roughly a 25% reduction in major cardiovascular events.

STRENGTH, testing high-dose combined EPA and DHA in about 13,000 people, was stopped early for showing no benefit at all.

The discrepancy is genuinely unresolved. REDUCE-IT used mineral oil as its placebo, and some researchers argue that may have slightly worsened outcomes in the comparison group, inflating the apparent benefit. Analyses attempting to reconcile the two trials continue to be published, which tells you the question is live rather than settled.

Either way, this exception describes prescription EPA in high-risk patients on statins. It says nothing about a supermarket capsule taken by someone healthy.

Where I’d correct the popular version#

The atrial fibrillation argument is the one most often deployed against fish oil, and it needs more precision than it usually gets.

The dose relationship is the whole story. High doses of 2–4 g/day increase AF risk substantially — figures around 50% appear in pooled analyses — while doses at or below 1 g/day show little to no effect. The signal is concentrated in pharmacological, prescription-strength omega-3 rather than in standard supplements.

It gets more complicated still. Analyses of plasma omega-3 levels find higher circulating omega-3 associated with lower AF risk, and when age is properly adjusted for, fish oil supplement use has not consistently shown increased AF risk. Some recent meta-analyses directly challenge the association.

And on the benefit side, pooled analyses covering around 149,000 participants suggest EPA monotherapy and combined EPA/DHA may reduce cardiovascular mortality, with EPA showing the more pronounced effect — which sits awkwardly against the two large null trials.

So the honest summary is not “no benefit, real harm.” It’s: standard doses show little benefit and little harm; high doses show contested benefit and a clearer AF signal. The case against the capsule rests on it probably doing nothing useful, not on it being dangerous.

Which doesn’t change the recommendation
#

The argument for eating fish rather than swallowing a capsule survives all of that, and rests on different ground.

Two portions a week of oily fish — mackerel, sardines, salmon, herring — meets the general omega-3 target while also supplying vitamin D, complete protein, selenium, iodine, B12, and calcium where small bones are eaten. A capsule isolates one molecule from that.

There’s a second, less obvious cost. Whatever occupies the plate instead of fish is, more often than not, ultra-processed. Skipping the fish loses what it would have added and gains the harm of the replacement. That displacement effect is easy to miss when comparing a capsule against fish on omega-3 content alone.

And there’s a behavioural cost worth naming: taking a supplement produces the sensation of having handled the health question for the day, which makes it easier to keep deferring the things that actually move outcomes — diet, movement, sleep, stress, relationships. A pill is a satisfying substitute for a decision.

Summary
#

Large randomised trials in around 25,000 healthy adults and 15,000 people with diabetes found standard-dose fish oil produced no meaningful reduction in heart attack, stroke or death. High-dose prescription EPA showed benefit in REDUCE-IT but not in STRENGTH, and the mineral-oil placebo leaves that unresolved. The atrial fibrillation risk is real but dose-dependent, appearing at 2–4 g/day rather than at typical supplement doses — and higher circulating omega-3 actually associates with lower AF risk. The case for eating fish instead rests on the whole nutritional package and on what replaces fish when it’s absent, not on the capsule being harmful.

What to actually do:

  1. If you’re healthy and taking a capsule for heart protection, it probably isn’t doing that. Two large trials looked and didn’t find it.
  2. Eat two portions of oily fish weekly — tinned sardines and mackerel are cheap and make this realistic.
  3. Don’t panic about AF at standard doses. That signal belongs to 2–4 g/day, not to a typical supplement.
  4. If you’re on prescription high-dose EPA, keep taking it — that’s a different intervention in a different population.
  5. Notice what replaces the fish if you skip it. The displacement is half the cost.
  6. Redirect the money toward something with a clearer return — decent food, shoes, a gym membership.
  7. If you genuinely won’t eat fish, a standard supplement is a reasonable fallback: it won’t do much, and it won’t hurt.

Education, not medical advice. Don’t change prescribed medication on the strength of an article.

Sources & further reading
#

  • Unraveling the discrepancies between REDUCE-IT and STRENGTH trials with omega-3 fatty acids: new analytical approaches — PMC
  • Effect of omega-3 polyunsaturated fatty acids on cardiovascular outcomes in patients with diabetes: a meta-analysis of randomized controlled trials — PMC
  • Associations between plasma omega-3 and fish oil use with risk of atrial fibrillation in the UK Biobank, Journal of the American Heart Association — AHA Journals
  • Omega-3, atrial fibrillation, and cardiovascular outcomes, JACC (2023) — JACC
  • Effect of high-dose marine omega-3 fatty acids on atherosclerosis: a systematic review and meta-analysis of randomized clinical trials — PMC
  • Nutrition Insight, Meta-analysis challenges link between omega-3 supplements and atrial fibrillation risk — Nutrition Insight

Related

No Vegetable Unclogs Anything

·1132 words·6 mins· loading · loading
Nutrition Cardiovascular Health Cognitive Bias
No Vegetable Unclogs Anything # Nothing you eat clears an artery the way a plumber clears a drain. But three categories of vegetable, eaten consistently for years, measurably slow arterial ageing, keep existing plaque more stable, and lower blood pressure in controlled trials. That’s a smaller claim and a far better supported one. Third: cruciferous vegetables # Broccoli, cauliflower, cabbage, kale, Brussels sprouts. People eating these regularly show less calcification and hardening in artery walls — the kind visible on an X-ray as faint parallel lines tracking a vessel, and conspicuously absent in people with healthy arteries.

The Calcium Paradox Points at a Vitamin Nobody Names

·1335 words·7 mins· loading · loading
Nutrition Cardiovascular Health Biomarkers
The Calcium Paradox Points at a Vitamin Nobody Names # The same person can have thinning bones and hardening arteries at once — calcium leaving the skeleton and arriving in the vessel wall. Adding more calcium doesn’t fix that. It’s a routing problem, and the protein that does the routing needs a vitamin most people have never been told about. The finding that should have changed the conversation # Bolland et al. (2010, BMJ) pooled 15 randomised, placebo-controlled trials covering more than 12,000 participants over 40, all taking at least 500mg of calcium daily without co-administered vitamin D. The meta-analysis found calcium supplementation associated with increased risk of myocardial infarction — commonly cited at around a 30% relative increase.

Your Arteries Stiffen From Ordinary Days

·1236 words·6 mins· loading · loading
Cardiovascular Health Cardio & Movement Nutrition
Your Arteries Stiffen From Ordinary Days # Three hours of uninterrupted sitting measurably reduces your leg arteries’ ability to widen. Twice-daily antiseptic mouthwash raises systolic pressure by 2–3 mmHg within a week. Neither feels like a health decision. Both are. Why stiffness is the variable to watch # Arterial stiffness tracks with heart attack, stroke, kidney disease, and dementia risk. It’s not an abstraction — advanced calcification is visible on imaging as mineral deposited in vessel walls, sitting alongside bone in the same picture.